Rixa Health

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• Compounded semaglutide with B12, oral dissolving tabletCompounded · not FDA-approved

What they publish

Rixa Health publishes 8 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

No membership published on the pages we captured

Medication cost

Compounded semaglutide/B12 oral dissolving tablets published by dose and supply: 30 days at $140 (2mg/0.5mg), $180 (5mg/0.5mg) and $225 (12mg/0.5mg); 90 days published at $295 and $395. Separately publishes that brand-name GLP-1s cost $800 to $1,300 per month without insurance (as published)

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

States coverage depends on the drug and the plan, that diabetes use is often covered while weight loss may not be, and that discounts or assistance programmes may lower costs.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

One-to-one consultation with a provider reviewing medical history, BMI, lab work and lifestyle factors before a plan is agreed. States 24/7 access and that adolescent care is guided by board-certified providers experienced in that age group.

Eligibility

For the adolescent programme, states eligibility is assessed on medical history, BMI, lab work and lifestyle at an initial consultation, with treatment prescribed only when medically appropriate and always combined with education, nutrition guidance and behavioural support. A specific adult BMI threshold was not published on the pages we captured.

Lab work

States custom functional lab work is part of its model, with regular medical monitoring and lab testing in the adolescent programme.

Pharmacy fulfilment

States medication comes from US pharmacies. The pharmacies are not named.

Shipping

States US pharmacies and fast shipping.

Support services

States education, nutrition guidance and behavioural support accompany medication, with regular monitoring in the adolescent programme.

Cancellation

Cancellation terms were not published on the pages we captured.

Refunds

Refund terms were not published on the pages we captured.

What stands out

• Publishes the exact milligram strength against every price — 2mg, 5mg and 12mg of semaglutide with 0.5mg B12 — which is more specific than almost anything else in this directory and lets you see precisely what you are buying.
• Its adolescent programme is framed carefully: medication only when medically appropriate, always with education, nutrition and behavioural support, lab monitoring, and a one-to-one consultation involving the parent.
• The teen page states semaglutide is FDA-approved for ages 16 and older. The adolescent approval for chronic weight management is Wegovy from age 12, and the compounded oral preparation sold here is not FDA-approved at any age — so it is worth establishing which product that sentence refers to.
• Publishes a realistic brand-name cost range of $800 to $1,300 a month without insurance, and correctly notes that diabetes indications are more often covered than weight loss.
• Sells an oral dissolving tablet rather than an injection. There is no published absorption or efficacy evidence for compounded oral semaglutide at these doses.
• The doses quoted are total tablet content rather than a weekly injectable equivalent, so they are not directly comparable to injection dosing.
• The pharmacies are not named, and no refund or cancellation terms are published.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• Which product does the FDA-approval statement on the teen page refer to? The compounded oral tablet sold here is not FDA-approved at any age.
• For an adolescent, what is the monitoring schedule, who else is involved in the decision, and what is the plan for stopping?
• What evidence supports oral dissolving semaglutide being absorbed at the intended dose?
• How do the 2mg, 5mg and 12mg tablet strengths relate to standard weekly injectable dosing?
• Which pharmacy compounds it, and is it a 503A or 503B?
• No refund or cancellation terms are published.

Frequently asked